Abzena ltd

Bioconjugate Development

Benefit from access to Abzena’s wide range of expertise and technology to streamline your bioconjugate development programComplete target to manufacturing service offering for all bioconjugate components including final conjugation

Generate a matrix of candidates for ex-vivo assessment before committing to further development

Develop a Matrix

At Abzena we understand that there is no one solution to the development of bioconjugates and that every target brings its own set of challenges to development.Abzena can help guide your development and manufacture of bioconjugates and ADCs through testing and characterisation to find the ideal conjugate for your patients.

Accelerate Bioconjugate Development

Abzena’s customised services accelerate the selection of the optimal candidates for your target of interest. Different conjugations technologies can be assessed side by side for efficacy allowing the ability to screen and rank multiple product candidates to optimise your investment right from the beginning.

Abzena enables you to make an informed decision regarding which conjugation technology is best suited for your target of interest regarding stability, off-target toxicity and efficacy. In addition, you will have peace of mind that the conjugation methods are simple, scalable and reproducible reducing manufacturing and characterization costs.Following screening, you can then move into Abzena’s manufacturing stream allowing accelerated production of small batches of non-GMP candidate ADCs.